Biohybrid Microrobots Offer New Strategy for Spinal Cord Injury Repair

Researchers at ETH Zurich have developed biohybrid microrobots capable of delivering stem cells to spinal cord injury sites, where they are stimulated by magnetic fields to promote nerve repair. According to a study published in Nature Materials, this approach bypasses the need for invasive implanted electrodes by using magnetoelectric nanoparticles to convert magnetic signals into the electrical stimulation required for nerve regeneration.

How Biohybrid Microrobots Work

The technology relies on “NPCbots,” which are created by combining neural progenitor cells (NPCs) with magnetoelectric nanoparticles. These nanoparticles feature a dual-layer design: an inner core sensitive to external magnetic fields and an outer shell of barium titanate that converts those magnetic signals into localized electrical impulses.

Once injected into the site of a spinal cord injury, these microrobots are guided by external electromagnetic fields. When the magnetic field is activated, the nanoparticles generate the electrical current necessary to stimulate the stem cells, encouraging them to differentiate into functional nerve cells. This process effectively replaces the traditional, more invasive method of using surgically implanted electrodes and wires to provide the electrical stimulation required for tissue integration.

Evidence of Nerve Regeneration in Animal Models

The research team, led by Professor Salvador Pané i Vidal, tested the NPCbots in two distinct animal models to measure regenerative potential. In zebrafish larvae, which possess a natural capacity for spinal cord regeneration, the application of NPCbots led to a recovery of normal swimming and exploratory behavior within three days of treatment.

The results in mice were particularly notable, as the mammalian spinal cord does not typically regenerate after a complete severance. After 28 days of treatment, researchers observed that the mice’s nerve cells had reconnected at the injury site. The treated subjects showed significant improvements in gait, coordination, and stride length. According to the ETH Zurich findings, the treatment was well-tolerated by the animals, with no reported adverse immune responses or toxicity during the study period.

Comparison with Current Clinical Approaches

Current standards for treating spinal cord injuries often rely on direct stem cell transplantation or the use of implanted electrical stimulation devices. These methods face significant limitations, including the risk of poor cell survival, the inability of transplanted cells to integrate into existing tissue, and the surgical trauma associated with implanting electrodes.

| Feature | Traditional Methods | NPCbot Approach |
| :— | :— | :— |
| Stimulation | Implanted electrodes/cables | External magnetic field |
| Invasiveness | High (surgical implantation) | Low (minimally invasive injection) |
| Cell Integration | Often poor survival rates | Enhanced by electrical stimulation |
| Precision | Low | High (magnetic guidance) |

Path Toward Clinical Application

While the animal studies demonstrate significant promise, the technology remains in the preclinical phase. Before human trials can be considered, researchers must address several critical hurdles. These include determining the optimal intensity and duration of magnetic stimulation for human physiology and conducting long-term studies to observe how the barium titanate nanoparticles are cleared or degraded by the body.

Beyond spinal cord repair, the research team suggests that the lab-on-a-chip platform used to produce these microrobots could be adapted for other medical fields. Potential future applications include targeted drug delivery in oncology, cardiac tissue repair, and accelerated wound healing. By refining the scalability of the production process, the team aims to transition the technology from basic research toward reliable, clinical-grade regenerative therapies.